Ya-Fei Kang Selected Research

lirinidine

4/2014

Antioxidant and anticancer constituents from the leaves of Liriodendron tulipifera.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ya-Fei Kang Research Topics

Disease

1	Hypertension (High Blood Pressure) 04/2022
1	Atherosclerosis 04/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2022
1	Thrombosis (Thrombus) 04/2022
1	Brain Diseases (Brain Disorder) 01/2021
1	Nasopharyngeal Carcinoma 01/2021
1	Neuroinflammatory Diseases 06/2020
1	Melanoma (Melanoma, Malignant) 04/2014
1	Breast Neoplasms (Breast Cancer) 12/2011
1	Neoplasms (Cancer) 12/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2011
1	Pituitary Neoplasms (Pituitary Adenoma) 02/2011
1	Hyperprolactinemia 02/2011

Drug/Important Bio-Agent (IBA)

1	Thrombin FDA Link 04/2022
1	protease-activated receptor 4IBA 04/2022
1	ResveratrolIBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	LipopolysaccharidesIBA 06/2020
1	hispidulinIBA 06/2020
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2020
1	lirinidineIBA 04/2014
1	lysicamineIBA 04/2014
1	anonaineIBA 04/2014
1	Glutathione Transferase (Glutathione S-Transferase)IBA 12/2011
1	protoapigenoneIBA 12/2011
1	Acetylcysteine (Siran)FDA LinkGeneric 12/2011
1	AntioxidantsIBA 12/2011
1	Sulfhydryl Compounds (Thiols)IBA 12/2011
1	Matrix Metalloproteinases (MMPs)IBA 12/2011
1	Mitogen-Activated Protein KinasesIBA 12/2011
1	ApigeninIBA 12/2011
1	Pharmaceutical PreparationsIBA 02/2011
1	Methadone (Dolophine)FDA LinkGeneric 02/2011
1	Opioid Analgesics (Opioids)IBA 02/2011
1	pyrrolineIBA 02/2011

Therapy/Procedure

1	Radiotherapy 01/2021